Stock listing
BOATS:ARQT Arcutis Biotherapeutics, Inc. Stock
US listing (BOATS) of Arcutis Biotherapeutics, Inc. · home listing NASDAQ:ARQT
Follow Arcutis Biotherapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ARQT
$26.36 USD -1.25 (-4.5%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ARQT
- Day range
- $26.29 – $27.46 USDNov 20, 2026
- Volume
- 1.29M sharesNov 20, 2026
- Market cap
- $3.33B USDAt the close on Nov 20, 2026 · price × 126.5M shares outstanding
- 52-week range
- $19.30 – $34.80 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $70.07M USDMedian day 1.95M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ARQT · Home | $26.36 USD | -1.25 (-4.5%) | 1,290,015 | $26.89 | $27.46 | $26.29 | $27.61 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ARQT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $26.36 | -1.25 | -4.5% | $26.89 | $27.46 | $26.29 | 1,290,015 | |
| $27.61 | +0.28 | +1.0% | $27.31 | $27.80 | $27.10 | 836,433 | |
| $27.33 | +0.18 | +0.7% | $27.13 | $27.59 | $26.84 | 1,315,539 | |
| $27.15 | -1.11 | -3.9% | $28.31 | $28.40 | $27.03 | 1,700,287 | |
| $28.26 | +0.73 | +2.7% | $27.50 | $28.33 | $27.06 | 858,150 | |
| $27.53 | -0.85 | -3.0% | $28.24 | $28.91 | $27.45 | 1,894,583 | |
| $28.38 | +0.995 | +3.6% | $27.50 | $28.65 | $27.20 | 2,456,746 | |
| $27.39 | +1.185 | +4.5% | $25.86 | $27.62 | $25.82 | 2,223,701 | |
| $26.20 | +0.65 | +2.5% | $25.78 | $26.42 | $25.23 | 2,636,046 | |
| $25.55 | -1.45 | -5.4% | $26.70 | $27.09 | $25.31 | 3,262,254 | |
| $27.00 | -7.05 | -20.7% | $29.00 | $29.49 | $25.78 | 7,600,825 | |
| $34.05 | +2.05 | +6.4% | $32.89 | $34.80 | $31.87 | 2,606,280 | |
| $32.00 | +0.74 | +2.4% | $31.32 | $32.39 | $31.27 | 1,617,363 | |
| $31.26 | -0.81 | -2.5% | $32.08 | $32.24 | $31.20 | 1,514,425 | |
| $32.07 | +0.10 | +0.3% | $32.34 | $32.56 | $31.67 | 1,882,616 | |
| $31.97 | +0.52 | +1.7% | $31.40 | $32.08 | $31.37 | 1,751,444 | |
| $31.45 | -0.23 | -0.7% | $31.50 | $32.00 | $31.39 | 1,669,286 | |
| $31.68 | -0.13 | -0.4% | $31.41 | $32.11 | $31.18 | 2,222,115 | |
| $31.81 | +0.61 | +2.0% | $31.41 | $32.26 | $31.35 | 1,547,666 | |
| $31.20 | -1.00 | -3.1% | $32.13 | $32.13 | $30.91 | 1,894,086 | |
| $32.20 | +0.33 | +1.0% | $31.68 | $32.50 | $31.35 | 2,075,750 | |
| $31.87 | -0.95 | -2.9% | $32.65 | $32.94 | $31.65 | 1,688,764 | |
| $32.82 | +0.93 | +2.9% | $31.89 | $33.30 | $31.75 | 4,490,710 | |
| $31.89 | +3.07 | +10.7% | $29.41 | $33.01 | $28.99 | 5,795,572 | |
| $28.82 | -0.28 | -1.0% | $29.18 | $29.37 | $28.15 | 1,801,700 | |
| $29.10 | +2.69 | +10.2% | $26.93 | $29.46 | $26.93 | 3,955,500 | |
| $26.41 | +0.32 | +1.2% | $26.01 | $26.94 | $25.86 | 1,643,000 | |
| $26.09 | -0.13 | -0.5% | $25.93 | $26.57 | $25.60 | 1,888,700 | |
| $26.22 | -0.36 | -1.4% | $26.54 | $26.82 | $25.97 | 1,556,700 | |
| $26.58 | +2.09 | +8.5% | $24.50 | $26.97 | $24.30 | 1,731,400 | |
| $24.49 | +0.32 | +1.3% | $23.91 | $24.57 | $23.37 | 2,605,900 | |
| $24.17 | +0.25 | +1.0% | $23.74 | $24.38 | $23.51 | 1,726,000 | |
| $23.92 | -1.23 | -4.9% | $25.37 | $25.37 | $23.89 | 2,573,000 | |
| $25.15 | -0.01 | 0.0% | $25.09 | $25.39 | $24.69 | 2,310,300 | |
| $25.16 | -0.13 | -0.5% | $25.64 | $25.78 | $25.01 | 1,778,400 | |
| $25.29 | -1.14 | -4.3% | $26.10 | $26.44 | $25.22 | 1,637,400 | |
| $26.43 | -0.32 | -1.2% | $27.00 | $27.39 | $26.41 | 2,391,400 | |
| $26.75 | -0.58 | -2.1% | $27.21 | $27.64 | $26.73 | 2,936,900 | |
| $27.33 | +0.41 | +1.5% | $26.70 | $27.55 | $26.43 | 3,065,600 | |
| $26.92 | +0.65 | +2.5% | $26.55 | $27.09 | $25.80 | 2,040,000 | |
| $26.27 | -0.11 | -0.4% | $26.22 | $26.68 | $25.19 | 2,177,400 | |
| $26.38 | -1.40 | -5.0% | $27.79 | $28.02 | $26.07 | 2,512,200 | |
| $27.78 | +1.82 | +7.0% | $25.90 | $28.29 | $25.69 | 2,857,800 | |
| $25.96 | +0.58 | +2.3% | $25.57 | $26.08 | $25.19 | 1,888,200 | |
| $25.38 | -1.08 | -4.1% | $26.14 | $26.75 | $25.13 | 19,136,900 | |
| $26.46 | +0.32 | +1.2% | $25.95 | $26.62 | $24.35 | 5,862,600 | |
| $26.14 | +2.63 | +11.2% | $23.63 | $26.39 | $23.63 | 5,155,400 | |
| $23.51 | -0.76 | -3.1% | $24.23 | $24.28 | $23.10 | 3,459,300 | |
| $24.27 | +0.385 | +1.6% | $23.79 | $24.75 | $23.79 | 2,031,500 | |
| $23.89 | +0.505 | +2.2% | $23.63 | $24.18 | $23.55 | 2,044,700 | |
| $23.38 | -0.46 | -1.9% | $23.70 | $23.84 | $23.25 | 1,784,900 | |
| $23.84 | -0.55 | -2.3% | $24.05 | $24.46 | $23.74 | 2,314,300 | |
| $24.39 | +0.49 | +2.1% | $24.84 | $25.13 | $24.09 | 4,560,362 | |
| $23.90 | +0.24 | +1.0% | $23.27 | $24.02 | $23.27 | 1,624,400 | |
| $23.66 | -0.19 | -0.8% | $24.13 | $24.13 | $23.47 | 1,122,300 | |
| $23.85 | +0.10 | +0.4% | $23.95 | $24.45 | $23.40 | 1,950,700 | |
| $23.75 | -0.22 | -0.9% | $23.79 | $24.11 | $23.54 | 1,101,600 | |
| $23.97 | +0.19 | +0.8% | $23.75 | $24.07 | $23.21 | 1,522,500 | |
| $23.78 | -1.09 | -4.4% | $24.60 | $24.88 | $23.74 | 1,535,900 | |
| $24.87 | -0.27 | -1.1% | $24.95 | $25.15 | $24.60 | 2,204,600 | |
| $25.14 | +0.28 | +1.1% | $24.85 | $25.50 | $24.45 | 1,911,300 | |
| $24.86 | +0.08 | +0.3% | $25.01 | $25.34 | $24.75 | 1,185,616 | |
| $24.78 | -0.30 | -1.2% | $24.80 | $25.21 | $24.49 | 1,128,432 | |
| $25.08 | -0.27 | -1.1% | $25.49 | $25.67 | $24.73 | 2,159,300 | |
| $25.35 | -1.11 | -4.2% | $26.50 | $26.56 | $24.53 | 3,289,300 |
- Ticker
- BOATS:ARQT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 13, 2026
Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting
Latest earnings call · Nov 4, 2026
Arcutis Biotherapeutics (NASDAQ:ARQT) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 5, 2026
Q2 2026 Earnings Presentation
Earnings · 17 slides
Calls
Replays
Arcutis Biotherapeutics (NASDAQ:ARQT) Q3 2026 Earnings Call
Wed, Nov 04, 2026 · 4:30 PM ET
Watch TranscriptArcutis Biotherapeutics (NASDAQ:ARQT) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptArcutis Biotherapeutics (NASDAQ:ARQT) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting
Nov 13, 2026
Closed $28.26 (+2.7%) on Nov 13, 2026
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nov 6, 2026
Closed $26.20 (+2.5%) on Nov 9, 2026
Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis
Nov 5, 2026
Closed $27.00 (-20.7%) on Nov 5, 2026
Arcutis Announces Third Quarter 2026 Financial Results and Provides Business Update
Nov 4, 2026
Closed $27.00 (-20.7%) on Nov 5, 2026
Arcutis Appoints Rob Scott, MD to Board of Directors
Oct 28, 2026
Closed $31.45 (-0.7%) on Oct 28, 2026
Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
Oct 27, 2026
Closed $31.45 (-0.7%) on Oct 28, 2026
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
Oct 21, 2026
Closed $32.20 (+1.0%) on Oct 22, 2026
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
Oct 9, 2026
Closed $26.58 (+8.5%) on Oct 9, 2026
Arcutis’ ZORYVE® (roflumilast) Wins 2026 Marie Claire Beauty Award
Oct 6, 2026
Closed $23.92 (-4.9%) on Oct 6, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 17 slides · Aug 5, 2026
Q1 2026 Earnings Presentation
Earnings · 22 slides · May 6, 2026
Q4 2025 Earnings Presentation
Earnings · 24 slides · Feb 25, 2026
Q2 2025 Earnings Presentation
Earnings · 23 slides · Aug 6, 2025
Arcutis Biotherapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 46 in the last 12 months · 258 in all · newest Nov 13, 2026 · oldest 2020
- Calls
- 17 calls with a replay · 17 with a transcript · latest Nov 4, 2026
- Decks
- 28 decks · latest Aug 5, 2026
Where Arcutis Biotherapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ARQT · Home listing | NASDAQ | United States | USD |
| BOATS:ARQT · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Arcutis Biotherapeutics, Inc.